Hayashi, T.; Shibata, M.; Oe, S.; Miyagawa, K.; Honma, Y.; Harada, M.
Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma. Cancers 2020, 12, 3215.
https://doi.org/10.3390/cancers12113215
AMA Style
Hayashi T, Shibata M, Oe S, Miyagawa K, Honma Y, Harada M.
Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma. Cancers. 2020; 12(11):3215.
https://doi.org/10.3390/cancers12113215
Chicago/Turabian Style
Hayashi, Tsuguru, Michihiko Shibata, Shinji Oe, Koichiro Miyagawa, Yuichi Honma, and Masaru Harada.
2020. "Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma" Cancers 12, no. 11: 3215.
https://doi.org/10.3390/cancers12113215
APA Style
Hayashi, T., Shibata, M., Oe, S., Miyagawa, K., Honma, Y., & Harada, M.
(2020). Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma. Cancers, 12(11), 3215.
https://doi.org/10.3390/cancers12113215